caffeic acid phenethyl ester has been researched along with Alzheimer Disease in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 2 (66.67) | 2.80 |
| Authors | Studies |
|---|---|
| Han, Y; Li, B; Li, Z; Luo, Z; Wan, Q | 1 |
| He, W; Huang, Y; Li, M; Li, W; Luo, Y; Mei, Y; Pan, H; Wan, T; Wang, Q; Wang, Z; Xue, J; Zhang, Y | 1 |
| Balaha, M; Cataldi, A; De Filippis, B; di Giacomo, V | 1 |
1 review(s) available for caffeic acid phenethyl ester and Alzheimer Disease
| Article | Year |
|---|---|
CAPE and Neuroprotection: A Review.
Topics: Alzheimer Disease; Animals; Anti-Inflammatory Agents; Antifungal Agents; Antioxidants; Antiviral Agents; Apoptosis; Brain; Caffeic Acids; Humans; Inflammation; Ischemia; Neurodegenerative Diseases; Parkinson Disease; Phenylethyl Alcohol; Propolis; Psychotic Disorders; Seizures | 2021 |
2 other study(ies) available for caffeic acid phenethyl ester and Alzheimer Disease
| Article | Year |
|---|---|
CAPE-pNO
Topics: Alzheimer Disease; Animals; Animals, Outbred Strains; Autophagy; Brain Injuries; Caffeic Acids; Cell Line; Diabetes Mellitus, Experimental; Inflammation; Male; Mice; NF-E2-Related Factor 2; Oxidative Stress; Phenylethyl Alcohol | 2021 |
FA-97, a New Synthetic Caffeic Acid Phenethyl Ester Derivative, Protects against Oxidative Stress-Mediated Neuronal Cell Apoptosis and Scopolamine-Induced Cognitive Impairment by Activating Nrf2/HO-1 Signaling.
Topics: Alzheimer Disease; Animals; Apoptosis; Caffeic Acids; Cognitive Dysfunction; Disease Models, Animal; Glucosides; Heme Oxygenase-1; Humans; Male; Mice; Mice, Inbred Strains; Neurons; Neuroprotective Agents; NF-E2-Related Factor 2; Oxidative Stress; PC12 Cells; Phenylethyl Alcohol; Rats; RNA, Small Interfering; Scopolamine; Signal Transduction | 2019 |